The news today is exactly in line with what the company has set out to do as part of their long term strategy .
This has increased the fundamentals of the company; keep in mind the recent appointments (yesterday), the release today (explaining how much of a milestone achievement this is), and the amount of drugs we have in the pipeline.
I'm invested in quite a few stocks, and Novogen is the only one I'm completely at ease with.
On top of that, we have GK leading the charge - enough said.
NRT Price at posting:
27.5¢ Sentiment: Buy Disclosure: Held